Home » FDA, Roche Warn on Fake Avastin Entering U.S. Via Foreign Supplier
FDA, Roche Warn on Fake Avastin Entering U.S. Via Foreign Supplier
March 1, 2012
Counterfeit versions of Genentech’s cancer drug Avastin are circulating in the U.S. supply chain after 19 practitioners bought the drug from an unauthorized foreign supplier, the FDA and the Swiss-owned drugmaker warn.